Randomized phase 2 trial of nab-paclitaxel plus gemcitabine, ± capecitabine, cisplatin (paxg regimen) in metastatic pancreatic adenocarcinoma

Authors :: G. Pepe
S. Romi
Michele Reni
Paolo Giorgio Arcidiacono
Massimo Falconi
M. Chiaravalle
U. Peretti
E. Gritti
Claudio Doglioni
Chiara Pircher
Roberto Nicoletti
Luca Gianni
M. Macchini
Silvia Zanon
Paolo Passoni
Gianpaolo Balzano
Source :: Annals of Oncology. 28:vi44-vi45
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: Oncology
Cisplatin
medicine.medical_specialty
business.industry
Hematology
Metastatic Pancreatic Adenocarcinoma
Gemcitabine
Capecitabine
Regimen
Internal medicine
medicine
business
medicine.drug
Nab-paclitaxel

Tools